Applied UV, Inc. · OTC:AUVI
Applied UV — Investor Presentation (June 2023)
26 slides from Applied UV's investor presentation, Jun 7, 2023
Slide 1: Investor Presentation
March 2023 Nasdaq: AUVI, AUVIP B e t t e r A i r . B e t t e r L i g h t . B e t t e r B u s i n e s s . B e t t e r L i f e . ™️ Investor Presentation Global Leader in Integrated Innovations for Air and Surface Pathogen Elimination, LED Lighting and Hospitality Furnishings May 2023 Our Brands NASDA
Slide 2: Safe Harbor Statement
Safe Harbor Statement Nasdaq: AUVI, AUVIP This presentation may contain “forward-looking statements.” Forward-looking statements reflect the current view about future events. When used in this prospectus, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the neg
Slide 3: Investor Highlights
Investor Highlights Nasdaq: AUVI, AUVIP AUVI is a fully integrated sales and marketing company offering proprietary, patented air and surface (fixed, consumer, HVAC and mobile) pathogen elimination products, LED lighting and luxury mirrors and premium hospitality furnishings to global end users REVE
Slide 4: Investor Key Highlights Takeaways
Investor Key Highlights Takeaways Nasdaq: AUVI, AUVIP MARKET: UV Disinfection market is expected to reach $9 billion by 2026 - CDC estimates that 1 in 25 patients have at least one HAI annually & 3M serious infections occur every year 01 GROWING MARKET with total losses to U.S. economy of more than
Slide 5: UV Disinfection Market: Compelling Growth Drivers
UV Disinfection Market: Compelling Growth Drivers Nasdaq: AUVI, AUVIP Global air purifier market size is set to grow exponentially. It was valued at USD 9.24 billion in 2021 and is predicted to reach USD 22.84 billion by 2030; UV Disinfection market is expected to reach USD 9 billion by 2026 as tech
Slide 6: Deeper Dive - Product Overview
Deeper Dive - Product Overview Nasdaq: AUVI, AUVIP Lab validated, data driven pathogen elimination solutions for air and surface applications Air Purification Surface Disinfection Independently tested for and eliminates COVID-19 Independently tested for and eliminates OC-43, a surrogate for SARS Cov
Slide 7: Air Disinfection
Air Disinfection Nasdaq: AUVI, AUVIP o Co-Developed for use by NASA to provide safe, clean air o Destroys 99.99% of airborne bacteria, mold, fungi and viruses o Advanced bioconversion technology uses photocatalytic oxidation to fully destroy airborne bacteria, mold, fungi, viruses, volatile organic
Slide 8: Facility Level Disinfection Solutions
HVAC Air Disinfection Nasdaq: AUVI, AUVIP Facility Level Disinfection Solutions o Innovative HVAC air and coil disinfection solutions o Continuous in-room air disinfection technologies o Hospital-grade surface disinfection solutions o Patented air and surface technologies © Copyright 2022 Applied UV
Slide 9: PURONet UV IAQ Disinfection Control System
IAQ Monitoring Software Nasdaq: AUVI, AUVIP PURONet UV IAQ Disinfection Control System UV Safety, Control and Reporting All In One Place o First control system of its kind specifically designed for user-friendly operation o Controls PURO Fixtures within a room providing safe operation and data colle
Slide 10: Mobile Air Disinfection
Mobile Air Disinfection Nasdaq: AUVI, AUVIP o Laboratory validated 99.99%+ kill rate on viruses, bacteria, mold, odors and VOCS o NO harmful by-products o Rapid, portable, whole-room disinfection via patented 3-phase design (HEPA, UV-C, Carbon) o Proven and tested in facilities with EPA and FDA guid
Slide 11: Surface Disinfection
Surface Disinfection Nasdaq: AUVI, AUVIP Backed by Biosafety Level II and III labs, is proven to kill 99.99%+ of pathogens on surfaces including: • SARS-CoV-2 surrogate (OC-43), MRSA, H1N1, Candida Auris (C. auris), C. diff and E. coli • June 2022 Mt Sinai Medical Center Morningside Installed with A
Slide 12: Strong Business Case Use Across Multiple Verticals
Strong Business Case Use Across Multiple Verticals IAQ Product Suite From Small Applications to Commercial / Heavy Industrial Agriculture Transportation Healthcare Food and Beverage Post-harvest Food Distribution and Logistics Hospitals Winery, Dairy, Meat & Preservations and Cannabis from “Farm To
Slide 13: Competitive Advantages
Competitive Advantages Nasdaq: AUVI, AUVIP AUVI is one of the only research-backed, clinically-proven air and surface disinfection technology companies with international distribution and globally recognized end users with product co-developed for use by NASA Few Dominant Players Global Push Highly
Slide 14: Differentiator - Global Distribution Footprint
Differentiator - Global Distribution Footprint Nasdaq: AUVI, AUVIP Scandinavia Europe • One Major Distributor (Dental) • One Master Distributor • 20 Retailers Asia • Nine Dealer Distributors United States • 24 Dealers/Distributors • 5-10 New Direct Sales Vietnam • Nine Dealer Distributors South Amer
Slide 15: Backed By Compelling Research
Backed By Compelling Research Nasdaq: AUVI, AUVIP MRIGlobal, an independent, not-profit, Kansas City, Missouri Georgia State University Study – PURO™ Helo Effectiveness • Demonstrated effective removal of aerosolized SARS-CoV-2 ▪ Demonstrated effective removal of aerosolized SARS- virus from surface
Slide 16: Hospitality Segment
A global manufacturer of luxury and backlit mirrors, patented - disinfection mirrors utilizing the SteriLumen proprietary PCO technology and premium conference room and living space furnishings, specifically for the hospitality industry Hospitality Segment Nasdaq: AUVI, AUVIP © Copyright 2021 Applie
Slide 17: Munnworks
Backed By Compelling Research Nasdaq: AUVI, AUVIP MUNNWORKS OUR PROMISE: DESIGNS TO YOUR SPECS, WITHIN BUDGET AND DELIVERED ON-TIME. 100+ EMPLOYEES DOMESTIC MANUFACTURING FACILITIES: MT VERNON, NY – 50,000 SQ FT FACTORY BROOKLYN, NY – 100,000 SQ FT FACTORY PRODUCTS & SERVICES: LIGHTED MIRRORS HOSPIT
Slide 18: Single Source Lighting, Controls and Technology Provider
LED LIGHTING AND CONTROLS Nasdaq: AUVI, AUVIP Single Source Lighting, Controls and Technology Provider By offering more products and technologies, we help streamline decisions, save time and resources at the corporate level down through construction for new construction and renovation projects: o LE
Slide 19: Organic Growth - Marketing
Organic Growth - Marketing Nasdaq: AUVI, AUVIP Effective and efficient marketing that increases customer count and revenue and wins the hearts and minds of target audience Targeted Product by Integrated Marketing Performance Metrics Vertical Programs • Increase quality sales leads Airocide • Digital
Slide 20: Consolidated Statement of Operations
Consolidated Statement of Operations Nasdaq: AUVI, AUVIP Applied UV, Inc. and Subsidiaries Unaudited Condensed Interim Consolidated Statements of Operations For the Three Months Ended March 31, 2023 and 2022 Net Sales by Segment 2023 2022 (03/31/2023) Net Sales Cost of Goods Sold $ 10,654,483 8,732,
Slide 21: Cap Table
Cap Table Nasdaq: AUVI, AUVIP Preferred Stock Par Authorized / Outstanding Designated (as of June 7, 2023) Total Authorized $0.0001 20,000,000 Series A Cumulative Perpetual $0.0001 1,250,000 552,000 Series B Cumulative Perpetual $0.0001 1,250,000 1,250,000 Series C Cumulative Perpetual $0.0001 2,500
Slide 22: Experienced Leadership Team
Experienced Leadership Team Nasdaq: AUVI, AUVIP Max Munn Michael Riccio Brian Stern Andrew Lawrence Founder, CEO, President CFO President PURO UV President LED Supply CO and Director and Director • Mr. Munn has held this position at • Former CFO and Treasurer of • Co-Founder of both PURO • Co-Founde
Slide 23: Experienced, Independent Board
Experienced, Independent Board Nasdaq: AUVI, AUVIP • President/CEO GranCare Inc, acquired by Apollo and merged with Living Centers of America to form Mariner • Chairman Mariner Post-Acute Network • President/COO and Director American Medical International (AMI) • Chairman Alterra Healthcare • Invest
Slide 24: Scientific Advisory Board
Scientific Advisory Board Nasdaq: AUVI, AUVIP • Professor of Medicine at the Icahn School of Medicine at Mount Sinai and the Infection Prevention Medical Director for the eight-hospital Mount Sinai Health System in NY • Dr. Cumins received his medical degree from Emory University School of Medicine
Slide 25: Looking Ahead: 2023 and Beyond
Target Key Verticals Prioritize Organic Growth Scalability Moving from opportunistic to Leverage cross selling opportunities• Fully optimize Canon focused approach with proven key among brands driven by: Virginia contract Looking Ahead: verticals • Govt mandates for healthcare manufacturing initiati
Slide 26: Applied UV, Inc.
Contact: Nasdaq: AUVI, AUVIP Applied UV, Inc. Max Munn Founder, CEO, President and Director 150 N. Macquesten Parkway Mount Vernon, NY 10550 914-391-6464 Better Air. Better Light. Better Business. Better Life. ™️